ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

Infectious Diseases Society of America

Enders, J. F. (1969) · The Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,296

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191

Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

Cornely, O. A., Maertens, J. A., Winston, D. J., Perfect, J. R., Ullmann, A. J., Walsh, T. J., HELFGOTT, D. C., Hołowiecki, J., Stockelberg, D., Goh, Y. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,802

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

Kontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J., Andes, D. R., Baddley, J. W., Brown, J. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651263 · Cited by 1,456

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis

Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380

Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease

Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P. H., Langston, A. A., Tarantolo, S., Greinix, H., de Azevedo, W. M., Reddy, V. S., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,339

Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205

A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation

Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B. C., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P. J., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,164

A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039

Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever

Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979

Practice Guidelines for the Treatment of Candidiasis

Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927

Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia

Walsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszyńska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 907

Untitled work

(2006) · PubMed · Cited by 906

Anidulafungin versus Fluconazole for Invasive Candidiasis

Reboli, A. C., Rotstein, C., Pappas, P. G., Chapman, S. W., Kett, D. H., Kumar, D., Betts, R., Wible, M., Goldstein, B. P., Schranz, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066906 · Cited by 894

Management of Fever in Patients with Cancer and Treatment-Induced Neutropenia

Wood, A. J. J., & Pizzo, P. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305063281808 · Cited by 831

Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation--A Prospective, Randomized, Double-Blind Study

Slavin, M. A., Osborne, B., Adams, R. H., Levenstein, M. J., Schoch, H. G., Feldman, A. R., Meyers, J. D., & Bowden, R. A. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1545 · Cited by 814

Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry

Neofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., Webster, K., & Marr, K. (2009) · Clinical Infectious Diseases · doi:10.1086/595846 · Cited by 801

Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials

Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793

Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins

Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 775

Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation

van Burik, J. H., Ratanatharathorn, V., Stepan, D. E., Miller, C. B., Lipton, J. H., Vesole, D. H., Bunin, N., Wall, D. A., Hiemenz, J., Satoi, Y., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/422312 · Cited by 741

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

Kuse, E.-R., Chetchotisakd, P., da Cunha, C. A., Ruhnke, M., Barrios, C., Raghunadharao, D., Sekhon, J. S., Freire, A., Ramasubramanian, V., Demeyer, I., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60605-9 · Cited by 692

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

Pappas, P. G., Rotstein, C. M. F., Betts, R. F., Nucci, M., Talwar, D., De Waele, J. J., Vazquez, J. A., Dupont, B. F., Horn, D. L., Ostrosky-Zeichner, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/520980 · Cited by 638

Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases

Walsh, T. J., Hiemenz, J. W., Seibel, N. L., Perfect, J. R., Horwith, G., Lee, L., Silber, J. L., DiNubile, M. J., Reboli, A. C., Bow, E. J., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516353 · Cited by 623

Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601

Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study

Maertens, J. A., Theunissen, K., Verhoef, G. E. G., Verschakelen, J., Lagrou, K., Verbeken, E. K., Wilmer, A., Verhaegen, J., Boogaerts, M. A., & Eldere, J. V. (2005) · Clinical Infectious Diseases · doi:10.1086/496927 · Cited by 589

A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia

Wingard, J. R., White, M. H., Anaissie, E. J., Raffalli, J. T., Goodman, J., Arrieta, A. C., & L Amph/ABLC Collaborative Study Group (2000) · Clinical Infectious Diseases · doi:10.1086/317451 · Cited by 524

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

Kullberg, B., Sobel, J., Ruhnke, M., Pappas, P., Viscoli, C., Rex, J., Cleary, J., Rubinstein, E., Church, L., Brown, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67490-9 · Cited by 521

Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial

Marr, K. A., Seidel, K. D., Slavin, M. A., Bowden, R. A., Schoch, H. G., Flowers, M. E. D., Corey, L., & Boeckh, M. (2000) · Blood · doi:10.1182/blood.v96.6.2055 · Cited by 510

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects

Rex, J. H., Pappas, P. G., Karchmer, A. W., Sobel, J., Edwards, J. E., Hadley, S., Brass, C., Vazquez, J. A., Chapman, S. W., Horowitz, H. W., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374850 · Cited by 495

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

Wingard, J. R., Carter, S. L., Walsh, T. J., Kurtzberg, J., Small, T. N., Baden, L. R., Gersten, I. D., Mendizabal, A. M., Leather, H. L., Confer, D. L., et al. (2010) · Blood · doi:10.1182/blood-2010-02-268151 · Cited by 478

Mortality and Costs of Acute Renal Failure Associated with Amphotericin B Therapy

Bates, D. W., Su, L., Yu, D. T., Chertow, G. M., Seger, D. L., Gomes, D. R. J., Dasbach, E. J., & Platt, R. (2001) · Clinical Infectious Diseases · doi:10.1086/319211 · Cited by 451

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

Marr, K. A., Crippa, F., Leisenring, W. M., Hoyle, M., Boeckh, M., Balajee, S. A., Nichols, W. G., Musher, B., & Corey, L. (2003) · Blood · doi:10.1182/blood-2003-08-2644 · Cited by 440

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

Prentice, H. G., Hann, I. M., Herbrecht, R., Aoun, M., Kvaløy, S., Catovsky, D., Pinkerton, R., Schey, S., Jacobs, F., Oakhill, A., et al. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.2473063.x · Cited by 437

Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial

Winston, D. J., Maziarz, R. T., Chandrasekar, P. H., Lazarus, H. M., Goldman, M., Blumer, J. L., Leitz, G. J., & Territo, M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-9-200305060-00006 · Cited by 389

Empirical versus Preemptive Antifungal Therapy for High‐Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial

Cordonnier, C., Pautas, C., Maury, S., Vekhoff, A., Farhat, H., Suárez, F., Dhédin, N., Isnard, F., Adès, L., Kuhnowski, F., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597395 · Cited by 389

Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients

Lortholary, O., Desnos-Ollivier, M., Sitbon, K., Fontanet, A., Bretagne, S., & Dromer, F. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01128-10 · Cited by 362

Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007)

Lortholary, O., Gangneux, J.-P., Sitbon, K., Lebeau, B., de Monbrison, F., Le Strat, Y., Coignard, B., Dromer, F., & Bretagne, S. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03548.x · Cited by 331

Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial Therapy: A Randomized, Controlled Trial

Boogaerts, M., Winston, D. J., Bow, E. J., Garber, G., Reboli, A. C., Schwarer, A. P., Novitzky, N., Boehme, A., Chwetzoff, E., De Beule, K., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00010 · Cited by 321

A Randomized Double‐Blind Study of Caspofungin versus Amphotericin for the Treatment of Candidal Esophagitis

Villanueva, A., Arathoon, E. G., Gotuzzo, E., Berman, R. S., DiNubile, M. J., & Sable, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/323401 · Cited by 308

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

Pachl, J., Svoboda, P., Jacobs, F., Vandewoude, K., van der Hoven, B., Spronk, P., Masterson, G., Malbrain, M., Aoun, M., Garbino, J., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/503428 · Cited by 307

Factors associated with mortality in transplant patients with invasive aspergillosis

Baddley, J. W., Andes, D. R., Marr, K. A., Kontoyiannis, D. P., Alexander, B. D., Kauffman, C. A., Oster, R. A., Anaissie, E. J., Walsh, T. J., Schuster, M. G., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/652768 · Cited by 303

Randomized, Double‐Blind Clinical Trial of Amphotericin B Colloidal Dispersion vs. Amphotericin B in the Empirical Treatment of Fever and Neutropenia

White, M. H., Bowden, R. A., Sandler, E. S., Graham, M. L., Noskin, G. A., Wingard, J. R., Goldman, M., van Burik, J., McCabe, A., Lin, J. S., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/514672 · Cited by 303

-Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3)

Lamoth, F., Cruciani, M., Mengoli, C., Castagnola, E., Lortholary, O., Richardson, M. D., Marchetti, O., & (ECIL-3), O. B. O. T. T. E. C. O. I. I. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir897 · Cited by 296

A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis

Villanueva, A., Gotuzzo, E., Arathoon, E., Noriega, L. M., Kartsonis, N. A., Lupinacci, R. J., Smietana, J. M., DiNubile, M. J., & Sable, C. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01191-9 · Cited by 290

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY antimicrobial surveillance program (2008–2009)

Pfaller, M. A., Messer, S. A., Moet, G. J., Jones, R. N., & Castanheira, M. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.02.016 · Cited by 274

Management of Invasive Candidal Infections: Results of a Prospective, Randomized, Multicenter Study of Fluconazole Versus Amphotericin B and Review of the Literature

Anaissie, E. J., Darouiche, R. O., Abi-Said, D., Uzun, Ö., Mera, J., Gentry, L. O., Williams, T. M., Kontoyiannis, D. P., Karl, C., & Bodey, G. P. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.5.964 · Cited by 274

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007): Stable incidence but changing epidemiology of a still frequently lethal infection

Sipsas, N. V., Lewis, R. E., Tarrand, J., Hachem, R., Rolston, K. V., Raad, I. I., & Kontoyiannis, D. P. (2009) · Cancer · doi:10.1002/cncr.24507 · Cited by 269

Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases

Arathoon, E. G., Gotuzzo, E., Noriega, L. M., Berman, R. S., DiNubile, M. J., & Sable, C. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.451-457.2002 · Cited by 254

Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Mousset, S., Buchheidt, D., Heinz, W., Ruhnke, M., Cornely, O. A., Egerer, G., Krüger, W., Link, H., Neumann, S., Ostermann, H., et al. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1867-1 · Cited by 254

Itraconazole Oral Solution as Prophylaxis for Fungal Infections in Neutropenic Patients with Hematologic Malignancies: A Randomized, Placebo‐Controlled, Double‐Blind, Multicenter Trial

Menichetti, F., Del Favero, A., Martino, P., Bucaneve, G., Micozzi, A., Girmenia, C., Barbabietola, G., Pagano, L., Leoni, P., Specchia, G., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/515129 · Cited by 244

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation

Marks, D. I., Pagliuca, A., Kibbler, C. C., Glasmacher, A. G., Heußel, C. P., Kantecki, M., Miller, P. J. S., Ribaud, P., Schlamm, H. T., Solano, C., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08838.x · Cited by 239

Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials

Nucci, M., Anaissie, E., Betts, R. F., Dupont, B. F., Wu, C., Buell, D. N., Kovanda, L., & Lortholary, O. (2010) · Clinical Infectious Diseases · doi:10.1086/653935 · Cited by 228

Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction

Estcourt, L. J., Stanworth, S. J., Doree, C. J., Blanco, P., Hopewell, S., Trivella, M., & Massey, E. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005341.pub3 · Cited by 214

Micafungin Versus Liposomal Amphotericin B for Pediatric Patients With Invasive Candidiasis

Queiroz‐Telles, F., Berezin, E. N., Leverger, G., Freire, A., van der Vyver, A., Chotpitayasunondh, T., Konja, J., Diekmann-Berndt, H., Koblinger, S., Groll, A. H., et al. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31817275e6 · Cited by 210

A Randomized, Double-Blind, Parallel-Group, Dose-Response Study of Micafungin Compared with Fluconazole for the Treatment of Esophageal Candidiasis in HIV-Positive Patients

Wet, N. T. E. D., Llanos‐Cuentas, A., Suleiman, J. M. A. H., Baraldi, E., Krantz, E., Negra, M. D., & Diekmann-Berndt, H. (2004) · Clinical Infectious Diseases · doi:10.1086/423377 · Cited by 203

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies

Morgenstern, G. R., Prentice, A. G., Prentice, H. G., Ropner, J. E., Schey, S., & Warnock, D. W. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01465.x · Cited by 200

A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer

Winston, D. J., Hathorn, J. W., Schuster, M. G., Schiller, G. J., & Territo, M. C. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00457-x · Cited by 189

Fluconazole versus Amphotericin B in the treatment of Hematogenous Candidiasis: A matched cohort study

Anaissie, E. J., Vartivarian, S. E., Abi-Said, D., Uzun, Ö., Pinczowski, H., Kontoyiannis, D. P., Khoury, P. N., Papadakis, K., Gardner, A., RAAD, I. I., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)80072-6 · Cited by 184

Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia

Arendrup, M. C., Sulim, S., Holm, A., Nielsen, L. B., Nielsen, S. D., Knudsen, J. D., Drenck, N. E., Christensen, J. J., & Johansen, H. K. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00179-11 · Cited by 181

A Multicenter Randomized Trial Evaluating Posaconazole versus Fluconazole for the Treatment of Oropharyngeal Candidiasis in Subjects with HIV/AIDS

Vázquez, J. A., Skiest, D. J., Nieto, L., Northland, R., Sanne, I., Gogate, J. P., Greaves, W. L., & ISAACS, R. E. (2006) · Clinical Infectious Diseases · doi:10.1086/501457 · Cited by 171

Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death

Slavin, M. A., Sorrell, T. C., Marriott, D., Thursky, K., Nguyen, Q. A., Ellis, D. H., Morrissey, C. O., Chen, S. C.-A., & on behalf of the Australian Candidemia Study, A. S. F. I. D. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq053 · Cited by 163

Posaconazole for the Treatment of Azole-Refractory Oropharyngeal and Esophageal Candidiasis in Subjects with HIV Infection

Skiest, D. J., Vazquez, J. A., Anstead, G. M., Graybill, J. R., Reynes, J., Ward, D., Hare, R., Boparai, N., & Isaacs, R. (2007) · Clinical Infectious Diseases · doi:10.1086/511039 · Cited by 162

Adjuvant Corticosteroid Therapy for Chronic Disseminated Candidiasis

Legrand, F., Lecuit, M., Dupont, B., Bellaton, E., Huerre, M., Rohrlich, P.-S., & Lortholary, O. (2008) · Clinical Infectious Diseases · doi:10.1086/527390 · Cited by 157

Evaluation of Aspergillus PCR Protocols for Testing Serum Specimens

White, P. L., Mengoli, C., Bretagne, S., Cuenca‐Estrella, M., Finnström, N., Klingspor, L., Melchers, W. J. G., McCulloch, E., Barnes, R. A., Donnelly, J. P., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05316-11 · Cited by 156

A Multicenter, Open-Label Clinical Study of Micafungin (FK463) in the Treatment of Deep-seated Mycosis in Japan

Kohno, S., Masaoka, T., Yamaguchi, H., Mori, T., Urabe, A., Ito, A., Niki, Y., & IKEMOTO, H. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410020406 · Cited by 152

Itraconazole Oral Solution for Primary Prophylaxis of Fungal Infections in Patients with Hematological Malignancy and Profound Neutropenia: a Randomized, Double-Blind, Double-Placebo, Multicenter Trial Comparing Itraconazole and Amphotericin B

Harousseau, J., Dekker, A. W., Stamatoullas, A., Fassas, Α., Linkesch, W., Gouveia, J., Bock, R. D., Rovira, M., Seifert, W., Joosen, H., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1887-1893.2000 · Cited by 151

ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases

Ullmann, A. J., Cornely, O. A., DonneNy, J. P., Akova, M., Arendrup, M. C., Arıkan-Akdağlı, S., Bassetti, M., Billé, J., Calandra, T., Castagnola, E., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12037 · Cited by 150

A Randomized, Double-Blind, Multicenter Study of Caspofungin Versus Liposomal Amphotericin B for Empiric Antifungal Therapy in Pediatric Patients With Persistent Fever and Neutropenia

Maertens, J. A., Madero, L., Reilly, A. F., Lehrnbecher, T., Groll, A. H., Jafri, H. S., Green, M., Nania, J. J., Bourque, M. R., Wise, B. A., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181da2171 · Cited by 137

Fluconazole Compared with Ketoconazole for the Treatment of Candida Esophagitis in AIDS: A Randomized Trial

Laine, L., Dretler, R. H., Conteas, C. N., Tuazon, C., Koster, F. M., Sattler, F., Squires, K., & Islam, M. Z. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-8-655 · Cited by 131

Candida spp. with Acquired Echinocandin Resistance, France, 2004–20101

Dannaoui, E., Desnos-Ollivier, M., Garcia-Hermoso, D., Grenouillet, F., Cassaing, S., Baixench, M.-T., Bretagne, S., Dromer, F., Lortholary, O., & the French Mycoses Study Group (2012) · Emerging infectious diseases · doi:10.3201/eid1801.110556 · Cited by 130

Voriconazole Salvage Treatment of Invasive Candidiasis

Ostrosky-Zeichner, L. L., Lashof, A. M. L. O., Kullberg, B. J., & Rex, J. H. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1014-3 · Cited by 125

Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial

Viscoli, C., Castagnola, E., Van Lint, M. T., Moroni, C., Garaventa, A., Rossi, M. R., Fanci, R., Menichetti, F., Caselli, D., Giacchino, M., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00619-2 · Cited by 122

Treatment of invasive fungal infections in cancer patients—Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Böhme, A., Ruhnke, M., Buchheidt, D., Cornely, O. A., Einsele, H., Enzensberger, R., Hebart, H. F., Heinz, W., Junghanß, C., Karthaus, M., et al. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0622-5 · Cited by 122

Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial

Penack, O., Schwartz, S., Martus, P., Reinwald, M., Schmidt‐Hieber, M., Thiel, E., & Blau, I. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl128 · Cited by 116

Prospective Study of Amphotericin B Formulations in Immunocompromised Patients in 4 European Countries

Ullmann, A. J., Sanz, M. Á., Tramarin, A., Barnes, R. A., Wu, W., Gerlach, B., Krobot, K. J., Gerth, W. C., & on behalf of the Longitudinal Evaluation of Antifungal Drugs (LEAD I) Investigators (2006) · Clinical Infectious Diseases · doi:10.1086/505969 · Cited by 115

Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia

Philpott‐Howard, J., Wade, J. J., Mufti, G. J., Brammer, K. W., & Ehniniger, G. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.6.973 · Cited by 113

A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic Patients

Nucci, M., Biasoli, I., Akiti, T., Silveira, F., Solza, C., Barreiros, G., Spector, N., Derossi, A., & Pulcheri, W. (2000) · Clinical Infectious Diseases · doi:10.1086/313654 · Cited by 113

Randomized Trial of Itraconazole Oral Solution for Oropharyngeal Candidiasis in HIV/AIDS Patients

Graybill, J. R., Vázquez, J. A., Darouiche, R. O., Morhart, R. E., Greenspan, D., Tuazon, C. U., Wheat, L. J., CAREY, J. J., Leviton, I. M., Hewitt, R. G., et al. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00307-0 · Cited by 108

Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia

Gotzsche, P. C., & Johansen, H. (1997) · BMJ · doi:10.1136/bmj.314.7089.1238 · Cited by 105

A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemicCandida infections in intensive care patients

Abele‐Horn, M., Köpp, A., Sternberg, U., Ohly, A., Nagengast, O., Dauber, A., Russwurm, W., Büchinger, W., & Emmerling, P. (1996) · Infection · doi:10.1007/bf01713042 · Cited by 104

An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia

Glasmacher, A. G., Cornely, O. A., Ullmann, A. J., Wedding, U., Bodenstein, H., Wandt, H., Boewer, C., Pasold, R., Wolf, H., Hänel, M., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki440 · Cited by 104

Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) in cancer patients with fever and neutropenia

Anaissie, E. J., Vartivarian, S. E., Bodey, G. P., Legrand, C., Kantarjian, H. M., Abi-Said, D., Karl, C. L., & Vadhan‐Raj, S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)90006-6 · Cited by 95

Oropharyngeal Candidiasis in Patients with AIDS: Randomized Comparison of Fluconazole Versus Nystatin Oral Suspensions

Pons, V., Greenspan, D., Lozada-Nur, F. I., McPhail, L., Gallant, J. E., Tunkel, A. R., Johnson, C. C., McCarty, J. M., Panzer, H., Levenstein, M., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/513664 · Cited by 95

Clinically Driven Diagnostic Antifungal Approach in Neutropenic Patients: A Prospective Feasibility Study

Girmenia, C., Micozzi, A., Gentile, G., Santilli, S., Arleo, E., Cardarelli, L., Capria, S., Minotti, C., Cartoni, C., Brocchieri, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.8032 · Cited by 92

Hepatosplenic Yeast Infection in Patients with Acute Leukemia: A Diagnostic Problem

Anttila, V., Ruutu, P., Bondestam, S., Jansson, S. ‐., Nordling, S., Färkkilä, M. A., Sivonen, K., Castrén, M. K., & Ruutu, T. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.6.979 · Cited by 88

Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection

Vazquez, J. (2010) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s6660 · Cited by 87

Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes.

Pagano, L., Mele, L., Fianchi, L., Melillo, L. M. A., Martino, B., D’Antonio, D., Tosti, M. E., Posteraro, B., Sanguinetti, M., Trapè, G., et al. (2002) · PubMed · Cited by 87

Emergence ofCandida krusei infections after therapy of oropharyngeal candidiasis with fluconazole

Akova, M., Akalın, H., Uzun, Ö., & Gür, D. (1991) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967286 · Cited by 86

Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections

Sachs, U. J., Reiter, A., Walter, T., Bein, G., & Woessmann, W. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.00996.x · Cited by 85

Detection of acute and treated lesions of hepatosplenic candidiasis: Conparison of dynamic contrast‐enhanced CT and MR Imaging

Semelka, R. C., Shoenut, J. P., Greenberg, H. M., & Bow, E. J. (1992) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880020315 · Cited by 81

Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis

Barbaro, G., Barbarini, G., Calderon, W., Grisorio, B., Alcini, P., & Di Lorenzo, G. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8898629 · Cited by 78

Efficacy of Caspofungin in the Treatment of Esophageal Candidiasis Resistant to Fluconazole

Kartsonis, N., DiNubile, M. J., Bartizal, K., Hicks, P. S., Ryan, D., & Sable, C. A. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200210010-00009 · Cited by 77

Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital

Muñóz, P., Giannella, M., Fanciulli, C., Guinea, J., Valerio, M., Rojas, L., Rodríguez‐Créixems, M., & Bouza, E. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03338.x · Cited by 76

Antifungal use influences Candida species distribution and susceptibility in the intensive care unit

Fournier, P., Schwebel, C., Maubon, D., Vesin, A., Lebeau, B., Foroni, L., Hamidfar-Roy, R., Cornet, M., Timsit, J., & Pelloux, H. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr394 · Cited by 76

Caspofungin as Primary Antifungal Prophylaxis in Stem Cell Transplant Recipients

Chou, L. S., Lewis, R. E., Ippoliti, C. M., Champlin, R. E., & Kontoyiannis, D. P. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.12.1644 · Cited by 75

Prevention of fungal infections in the immunocompromised host.

Mahfouz, T. H., & Anaissie, E. J. (2003) · PubMed · Cited by 74

Recombinant interferon γ1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions

Safdar, A., Rodriguez, G. H., Lichtiger, B., Dickey, B. F., Kontoyiannis, D. P., Freireich, E. J., Shpall, E. J., RAAD, I. I., Kantarjian, H. M., & Champlin, R. E. (2006) · Cancer · doi:10.1002/cncr.21929 · Cited by 73

Epidemiology ofCandidablood stream infections in patients with hematological malignancies or solid tumors

Zirkel, J., Klinker, H., Kuhn, A., Abele‐Horn, M., Tappe, D., Turnwald, D., Einsele, H., & Heinz, W. (2012) · Medical Mycology · doi:10.3109/13693786.2011.587211 · Cited by 71

Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults

Bow, E. J., Evans, G. A., Fuller, J., Laverdière, M., Rotstein, C., Rennie, R. P., Shafran, S. D., Sheppard, D. C., Carle, S., Phillips, P., et al. (2010) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2010/357076 · Cited by 70

Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study

Cordonnier, C., Mohty, M., Faucher, C., Pautas, C., Robin, M., Vey, N., Monchecourt, F., Mahi, L., & Ribaud, P. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.10.001 · Cited by 70

Immunomodulation with interferon‐gamma and colony‐stimulating factors for refractory fungal infections in patients with leukemia

Dignani, M. C., Rex, J. H., Chan, K., Dow, G., Magalhaes-Silverman, M. D., Maddox, A., Walsh, T. J., & Anaissie, E. J. (2005) · Cancer · doi:10.1002/cncr.21142 · Cited by 69

A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients

Oren, I., Rowe, J. M., Sprecher, H., Tamir, A., Benyamini, N., Akria, L., Gorelik, A., Dally, N., Zuckerman, T., Haddad, N., et al. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705418 · Cited by 67

Candidemia in cancer patients: Impact of early removal of non-tunneled central venous catheters on outcome

Liu, C. Y., Huang, L. J., Wang, W. S., Chen, T. L., Yen, C. C., Yang, M. H., Hsiao, L. T., Liu, C. Y., Chen, P. M., & Chiou, T. J. (2009) · Journal of Infection · doi:10.1016/j.jinf.2008.12.008 · Cited by 67

Nystatin prophylaxis and treatment in severely immunodepressed patients

Gøtzsche, P. C., & Johansen, H. K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002033.pub2 · Cited by 66

Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia-related infections

Lee, J.-J., Chung, I.-J., Park, M.-R., Kook, H., Hwang, T., Ryang, D., & Kim, H.-J. (2001) · Leukemia · doi:10.1038/sj.leu.2402007 · Cited by 65

Beta- d -Glucan Detection as a Diagnostic Test for Invasive Aspergillosis in Immunocompromised Critically Ill Patients with Symptoms of Respiratory Infection: an Autopsy-Based Study

Vlieger, G. D., Lagrou, K., Maertens, J. A., Verbeken, E. K., Meersseman, W., & Wijngaerden, E. V. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00879-11 · Cited by 64

Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: A retrospective, observational, sequential cohort analysis

Kubiak, D. W., Porter, J., McDonnell, A., Delgado-Flores, J. O., Mui, E., Baden, L. R., & Marty, F. M. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.04.005 · Cited by 63

The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients

Chandrasekar, P. H., & Gatny, C. M. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.2.309 · Cited by 62

Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study

Kartsonis, N. A. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh179 · Cited by 61

Treatment of Candida Infections with Amphotericin B Lipid Complex

Ito, J. I., & Hooshmand-Rad, R. (2005) · Clinical Infectious Diseases · doi:10.1086/429330 · Cited by 60

A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia

Velasco, E., & Bigni, R. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0546-y · Cited by 59

Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B

Dupont, B., Lortholary, O., Ostrosky-Zeichner, L. L., Stucker, F., & Yeldandi, V. V. (2009) · Critical Care · doi:10.1186/cc8117 · Cited by 59

G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis

Grigull, L., Pulver, N., Goudeva, L., Sykora, K., Linderkamp, C., Beilken, A., Seidemann, K., Schmid, H., Welte, K., & Heuft, H. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0041-x · Cited by 57

Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients

Boogaerts, M. A. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.97 · Cited by 57

Breakthrough Candidemia in Patients with Cancer Differs from De Novo Candidemia in Host Factors andCandidaSpecies But Not Intensity

Kontoyiannis, D. P., Reddy, B. T., Hanna, H. A., Bodey, G. P., Tarrand, J. T., & RAAD, I. I. (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502104 · Cited by 55

Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients

Murray, P. A., Koletar, S. L., Mallegol, I., Wu, J., & Moskovitz, B. L. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80131-2 · Cited by 52

Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment, and prognosis

Chen, C., Chen, Y., Tang, J., Yao, M., Huang, S., Tsai, W., Chen, Y., Shen, M., Wang, C., & Tien, H. (2003) · Annals of Hematology · doi:10.1007/s00277-002-0588-7 · Cited by 50

Immune reconstitution syndrome and fungal infections

Gupta, A. O., & Singh, N. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834ab20a · Cited by 50

Amphotericin B Colloidal Dispersion for Treatment of Candidemia in Immunocompromised Patients

Noskin, G. A., Pietrelli, L. A., Coffey, G., Gurwith, M., & Liang, L.-J. F. (1998) · Clinical Infectious Diseases · doi:10.1086/516314 · Cited by 49

Prior Caspofungin Exposure in Patients with Hematological Malignancies Is a Risk Factor for Subsequent Fungemia Due to Decreased Susceptibility in Candida spp.: a Case-Control Study in Paris, France

Blanchard, É., Lortholary, O., Sitbon, K., Desnos‐Ollivier, M., Dromer, F., Guillemot, D., & the French Mycosis Study Group (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00690-11 · Cited by 47

Randomized, Comparative, Double-Blind, Double-Dummy, Multicenter Trial of Miconazole Buccal Tablet and Clotrimazole Troches for the Treatment of Oropharyngeal Candidiasis: Study of Miconazole Lauriad®Efficacy and Safety (SMiLES)

Vazquez, J. A., Patton, L. L., Epstein, J. B., Ramlachan, P., Mitha, I. H., Noveljic, Z., Fourie, J., Conway, B., Lalla, R. V., Barasch, A., et al. (2010) · HIV Clinical Trials · doi:10.1310/hct1104-186 · Cited by 46

A Phase 2, Open-Label Study of the Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis

Vázquez, J. A., Schranz, J., Clark, K., Goldstein, B. P., Reboli, A. C., & Fichtenbaum, C. J. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31817af47a · Cited by 45

Granulocyte transfusions for neutropenic patients with life‐threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions

Ofran, Y., Avivi, I. M., Oliven, A., Oren, I., Zuckerman, T., Bonstein, L., Rowe, J. M., & Dann, E. J. (2007) · Vox Sanguinis · doi:10.1111/j.1423-0410.2007.00971.x · Cited by 44

Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders

Tamura, K., Urabe, A., Yoshida, M., Kanamaru, A., Kodera, Y., Okamoto, S., Maesaki, S., & Masaoka, T. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802635500 · Cited by 44

Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction

Massey, E., Paulus, U., Doree, C. J., & Stanworth, S. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005341.pub2 · Cited by 42

Itraconazol‐Suspension in der Behandlung HIV‐infizierter Patienten mit Fluconazol‐resistenter oropharyngealer Candida‐Infektion und Soorösophagitis

Eichel, M., Just‐Nübling, G., Helm, E. B., & Stille, W. (1996) · Mycoses · doi:10.1111/j.1439-0507.1996.tb00514.x · Cited by 41

An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis

Lashof, A. M. L. O., Bock, R. D., Herbrecht, R., Pauw, B. E. D., Krcmery, V., Aoun, M., Akova, M., Cohen, J., Šiffnerová, H., Egyed, M., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.03.003 · Cited by 40

Nystatin prophylaxis and treatment in severely immunodepressed patients

Gøtzsche, P. C., & Johansen, H. K. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002033 · Cited by 39

Diagnosis and Monitoring Response to Treatment of Hepatosplenic Candidiasis in Patients with Acute Leukemia Using Magnetic Resonance Imaging

Sallah, S., Semelka, R. C., Kelekis, N., Worawattanakul, S., & Sallah, W. (1998) · Acta Haematologica · doi:10.1159/000040869 · Cited by 38

Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy*

Schuler, U. S., Bammer, S., Aulitzky, W. E., Binder, C. R., Böhme, A., Egerer, G., Sandherr, M., Schwerdtfeger, R., Silling, G., Wandt, H., et al. (2007) · Oncology Research and Treatment · doi:10.1159/000100055 · Cited by 35

Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients

Noskin, G. A., Pietrelli, L. A., Gurwith, M., & Bowden, R. A. (1999) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701630 · Cited by 33

Five-years surveillance of invasive aspergillosis in a university hospital

Graf, K., Khani, S. M., Ott, E., Mattner, F., Gastmeier, P., Sohr, D., Ziesing, S., & Chaberny, I. F. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-163 · Cited by 32

Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms

Nweze, E. I., Ghannoum, A., Chandra, J., Ghannoum, M. A., & Mukherjee, P. K. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr429 · Cited by 31

Pappas et al. (2007; 45:883–93)

(2008) · Clinical Infectious Diseases · doi:10.1086/590000 · Cited by 31

Fluconazole Compared with Itraconazole in the Treatment of Esophageal Candidiasis in AIDS Patients: A Double-blind, Randomized, Controlled Clinical Study

Bárbaro, G., Barbarini, G., & Lorenzo, G. D. (1995) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549509047076 · Cited by 30

Echinocandin Susceptibility Testing of Candida Isolates Collected during a 1-Year Period in Sweden

Elings, M. A., Botero-Kleiven, S., Hare, R. K., & Arendrup, M. C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00201-11 · Cited by 30

Efficacy of Fluconazole in the Treatment of Upper Gastrointestinal Candidiasis in Neutropenic Patients with Cancer: Factors Influencing the Outcome

Akova, M., Akalın, H., Uzun, Ö., Hayran, M., Tekuzman, G., Kansu, E., Asian, S., & TELATAR, H. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.3.298 · Cited by 29

Early detection of chronic disseminated Candida infection in leukemia patients with febrile neutropenia: value of computer-assisted serial ultrasound documentation

Karthaus, M., Huebner, G., Elser, C., Geißler, R. G., Heil, G., & Ganser, A. (1998) · Annals of Hematology · doi:10.1007/s002770050409 · Cited by 29

Fluconazole vs. Flucytosine in the Treatment of Esophageal Candidiasis in AIDS Patients: A Double-Blind, Placebo-Controlled Study

Barbaro, G., Barbarini, G., & Di Lorenzo, G. (1995) · Endoscopy · doi:10.1055/s-2007-1005717 · Cited by 27

Correlation of In Vitro Fluconazole Susceptibility with Clinical Outcome for Severely Ill Patients with Oropharyngeal Candidiasis

Arıkan, S., Akova, M., Hayran, M., Özdemir, O., Erman, M., Gür, D., & Ünal, S. (1998) · Clinical Infectious Diseases · doi:10.1086/513927 · Cited by 27

Candida spp. with Acquired Echinocandin Resistance, France,

Dannaoui, É., Desnos‐Ollivier, M., Garcia‐Hermoso, D., Grenouillet, F., Cassaing, S., Baixench, M.-T., Bretagne, S., Dromer, F., & Lortholary, O. (2012) · Cited by 27

Adjuvant Corticosteroid Therapy in 2 Children With Hepatosplenic Candidiasis-related IRIS

Saint-Faust, M., Boyer, C., Gari-Toussaint, M., Deville, A., Poirée, M., Weintraub, M., & Sirvent, N. (2009) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181b795ec · Cited by 26

Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA)

Ito, J. I., Chandrasekar, P. H., & Hooshmand-Rad, R. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705143 · Cited by 25

Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies

Hirata, Y., Yokote, T., Kobayashi, K., Nakayama, S., Oka, S., Miyoshi, T., Akioka, T., Hiraoka, N., Iwaki, K., Takayama, A., et al. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428191003682726 · Cited by 25

Infection: the new problems.

Rubin, R. H., & TOLKOFF-RUBIN, N. E. (1989) · PubMed · Cited by 25

Optimization of the Dosage of Flucytosine in Combination with Amphotericin B for Disseminated Candidiasis: a Pharmacodynamic Rationale for Reduced Dosing

Hope, W. W., Warn, P. A., Sharp, J., Reed, P., Keevil, B. G., Louie, A., Walsh, T. J., Denning, D. W., & Drusano, G. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00488-07 · Cited by 24

Granulocyte colony-stimulating factor-primed leukocyte transfusions in candida tropicalis fungemia in neutropenic patients.

Mario, A. D., Sica, S., Salutari, P., Barbera, E. O. L., Marra, R., & Leone, G. G. M. (1997) · PubMed · Cited by 23

Control of aCandida glabrataprosthetic endovascular infection with posaconazole

Anstead, G. M., Martinez, M., & Graybill, J. R. (2006) · Medical Mycology · doi:10.1080/13693780500049152 · Cited by 19

Successful intensive chemotherapy followed by autologous hematopoietic cell transplantation in a patient with acute myeloid leukemia and hepatosplenic candidiasis: case report and review of literature

Poon, L. M., Chia, H., Tan, L. ‐., Liu, T. ‐., & Koh, L. P. (2009) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2009.00363.x · Cited by 16

Caspofungin—a new therapeutic option for oropharyngeal candidiasis

Garbino, J. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1198-743x.2004.00823.x · Cited by 14

Caspofungin in the Treatment of Azole-Refractory Esophageal Candidiasis in Kidney Transplant Recipients

Veroux, M., Macarone, M., Fiamingo, P., Cappello, D., Gagliano, M., Mare, M. D., Vizcarra, D., Spataro, M., Giuffrida, G., Sorbello, M., et al. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.03.050 · Cited by 14

In Situ Liposomal Preparation Containing Amphotericin B: Related Toxicity and Tissue Disposition Studies

Chakraborty, K. K., & Suresh Ramnath, N. A. I. K. (2000) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100102037 · Cited by 11

Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients

Maertens, J. A., Huysmans, G., & Theunissen, K. (2008) · Current Infectious Disease Reports · doi:10.1007/s11908-008-0075-y · Cited by 9

Itraconazole IV solution in the treatment of candidemia in non-neutropenic patients

Tuil, O., & Cohen, Y. (2003) · Critical Care · doi:10.1186/cc2020 · Cited by 8

A reevaluation of nystatin in prophylaxis and treatment of oropharyngeal candidiasis.

Alvarez, M. E., Sánchez-Sousa, A., & Baquero, F. (1998) · PubMed · Cited by 7

The usefulness of the PlateliaCandidaantigen in a patient with acute lymphocytic leukemia and chronic disseminated candidiasis

Sun, H., Chiu, Y.-S., Tang, J., Wang, J., Chang, S., & Chen, Y. (2006) · Medical Mycology · doi:10.1080/13693780600735445 · Cited by 6

Infectious Complications from High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Metastatic Germ Cell Tumors

Jathavedam, A., Feldman, D. R., Ishill, N. M., Turkula, S., Patil, S., Bosl, G. J., Motzer, R. J., & Weinstock, D. M. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.02.020 · Cited by 5

ESCMID Diagnostic and management guideline for Candida diseases 2012: Developing European guidelines in clinical microbiology and infectious diseases.

Ullman, A. J., Cornely, O. A., Donnelly, P., et al. (2012) · Radboud Repository (Radboud University) · Cited by 5

Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.

Bárbaro, G., & Lorenzo, G. D. (1995) · PubMed · Cited by 5

Antifungal drugs: predicting clinical efficacy with pharmacodynamics

Nailor, M. D., & Chandrasekar, P. H. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.14 · Cited by 4

Invasive Candidiasis in the Neutropenic Cancer Patient

Gamaletsou, M. N., Sipsas, N. V., & Kontoyiannis, D. P. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0044-4 · Cited by 4

Fluconazole in the Treatment of Mycotic Oropharyngeal Stomatitis and Esophagitis in Neutropenic Cancer Patients

Krcmery, V., Koza, I., Horníková, M., Fuchsberger, P., Spanik, S., Mardiak, J., Šufliarský, J., Blahová, M., Савко, В. В., & Migom, C. (2009) · Chemotherapy · doi:10.1159/000238877 · Cited by 3

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200

Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision

Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556

ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014

Høiby, N., Bjarnsholt, T., Moser, C. E., Bassi, G. L., Coenye, T., Donelli, G., Hall‐Stoodley, L., Holá, V., Imbert, C., Kirketerp‐Møller, K., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.10.024 · Cited by 801

Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology

Ashbee, H. R., Barnes, R. A., Johnson, E. M., Richardson, M. D., Gorton, R., & Hope, W. W. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt508 · Cited by 721

P971 Amphotericin B does not affect the pharmacokinetics of micafungin (FK463)

Undre, N. A., Stevenson, P., & Wilbraham, D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(07)70812-9

Management of invasive mycoses in hematology patients: current approaches.

Perfect, J. R. (2004) · PubMed · Cited by 13

Candidaemia in Patients with Haematological Disorders and Stem Cell Transplant

Al‐Anazi, K. A., & Al-Jasser, A. M. (2006) · Libyan Journal of Medicine · doi:10.3402/ljm.v1i2.4673 · Cited by 5

Candidemia in Cancer Patients: Focus Mainly on Hematological Malignancyand Hematopoietic Stem Cell Transplantation

Okinaka, K. (2016) · Medical Mycology Journal · doi:10.3314/mmj.16.003 · Cited by 4

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

Tissot, F., Agrawal, S., Pagano, L., Petrikkos, G., Groll, A. H., Skiada, A., Lass-Flörl, C., Calandra, T., Viscoli, C., & Herbrecht, R. (2017) · Haematologica · doi:10.3324/haematol.2016.152900 · Cited by 682